Literature DB >> 22217486

The public cost of 3 statins for primary prevention of cardiovascular events in 7 Middle East countries: not all of them can afford it.

Hussain Isma'eel, Zeina Mohanna, Ghassan Hamadeh, Elie Alam, Kamal Badr, Samir Alam, Abdallah Rebeiz.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22217486     DOI： 10.1016/j.ijcard.2011.12.011

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  6 in total

1.  Disease-Related Costs Published in The Middle East and North Africa Region: Systematic Review and Analysis of Transferability.

Authors:  Zsombor Zrubka; Márta Péntek; Lea Mhanna; Teebah Abu-Zahra; Mohamed Mahdi-Abid; Meriem Fgaier; Faris El-Dahiyat; Hana Al-Abdulkarim; Michael Drummond; László Gulácsi
Journal:  Pharmacoeconomics       Date:  2022-05-17       Impact factor: 4.558

2.  Discrepancies between two lipid-lowering guidelines for CVD prevention in seemingly healthy individuals-case study Lebanon.

Authors:  Hussain Ali Isma'eel; Bernard Harbieh; Hani Tamim; Lara Nasreddine; Farah Naja; Abla Sibai; Nada Adra; Kamal Badr; Nahla Hwalla
Journal:  Cardiovasc Diagn Ther       Date:  2013-09

Review 3.  Costs associated with management of non-communicable diseases in the Arab Region: a scoping review.

Authors:  Shadi Saleh; Amena El Harakeh; Maysa Baroud; Najah Zeineddine; Angie Farah; Abla Mehio Sibai
Journal:  J Glob Health       Date:  2018-12       Impact factor: 4.413

4.  Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq.

Authors:  Ola A Nassr; Paul Forsyth; Chris F Johnson
Journal:  Pharm Pract (Granada)       Date:  2019-03-11

5.  Delivering a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: a descriptive costing study.

Authors:  Éimhín Ansbro; Sylvia Garry; Veena Karir; Amulya Reddy; Kiran Jobanputra; Taissir Fardous; Zia Sadique
Journal:  Health Policy Plan       Date:  2020-10-01       Impact factor: 3.344

6.  Optimal Medical Therapy for Secondary Prevention of Acute Coronary Syndrome: A Retrospective Study from a Tertiary Hospital in Sudan.

Authors:  Kannan O Ahmed; Ashraf M Ahmed; Mojahed B Wali; Ali H Ali; Mustafa M Azhari; Anas Babiker; Bashir A Yousef; Hiba F Muddather
Journal:  Ther Clin Risk Manag       Date:  2022-04-08       Impact factor: 2.423
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.